

%201.webp)


%201.webp)




LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。



%201.webp)


%201.webp)




序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

Kyrgyzstan has implemented a national pharmaceutical serialization and traceability framework as part of the Eurasian Economic Union (EAEU) digital marking initiative. The system is designed to improve medicine supply chain transparency, prevent counterfeit medicines, and enable regulatory monitoring of pharmaceutical distribution.
The national system requires medicines to carry serialized DataMatrix codes that allow regulators and supply chain participants to track pharmaceutical products from manufacturing or import through distribution and dispensing.
Kyrgyzstan operates its digital marking system through the State Tax Service marking platform, which forms part of the broader national digital product labeling program. Pharmaceutical products must be registered in the marking system, and serialized identifiers must be applied before products are placed on the market.
The framework is aligned with international identification standards and supports electronic reporting of supply chain events across the pharmaceutical distribution network.
Medicines distributed in Kyrgyzstan must include a 2D DataMatrix barcode applied to the secondary packaging.
The DataMatrix must follow the national digital marking requirements and typically contains the following elements:
These identifiers allow each pharmaceutical package to be uniquely identified and verified within the national traceability system.
The barcode must be printed on the packaging in accordance with national labeling and marking standards. Human readable information on the packaging must correspond to the encoded barcode data.
2019–2020
Kyrgyzstan began implementing national digital marking initiatives aligned with broader EAEU digital product labeling strategies.
2021
Pilot programs for digital marking and traceability were introduced across regulated product categories, including pharmaceuticals.
2022 onward
The serialization and traceability system has been progressively implemented for medicines within the national digital marking framework.
Supply chain participants must report product movement within the national marking system to ensure complete traceability.
Traceability reporting in Kyrgyzstan is managed through the national digital marking and traceability system operated by the State Tax Service.
The platform enables supply chain participants to interact with the system through electronic services and APIs.
Participants interacting with the platform include:
The system supports:
The Kyrgyzstan marking system primarily focuses on unit level serialization using DataMatrix codes.
Aggregation at case or pallet level is not explicitly mandated in the publicly available regulatory guidance. However, pharmaceutical manufacturers may implement aggregation internally to improve logistics efficiency and supply chain operations.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.